One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS)-Reference-Cited by-同舟云学术

One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS)

Published:2021-05-12 Issue:6 Volume:38 Page:3281-3298
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Chan Juliana C. N.,Gagliardino Juan José,Ilkova Hasan,Lavalle Fernando,Ramachandran Ambady,Mbanya Jean Claude,Shestakova Marina,Dessapt-Baradez Cecile,Chantelot Jean-Marc,Aschner Pablo

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-021-01736-4.pdf

Reference44 articles.

1. International Diabetes Federation. IDF Diabetes Atlas, 9th ed. 2019. https://diabetesatlas.org/en/resources/. Cited 6 Oct 2020.

2. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363(24):2339–50.

3. Luk AOY, et al. Diabetes-related complications and mortality in patients with young-onset latent autoimmune diabetes: a 14-year analysis of the prospective Hong Kong diabetes register. Diabetes Care. 2019;42(6):1042–50.